← Leaderboards
Megan Noonan
Indiana University Indianapolis
$89,727
Attributed
$89,727
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $32.6K · FY2019–21$50K$37.5K$25K$12.5K$0
'19
'20
'21
Funding mix
By agency
NIH$89,727 · 1
By mechanism
F31$89,727 · 1
Top collaborators
No co-investigators on record.
Most similar at Indiana University Indianapolis
Same institution · by research overlap
- Kenneth E White$12,659,578
- Sharon M Moe$24,308,038
- Erica L Clinkenbeard$2,166,527
- Megan Song McHenry$5,166,396
- Chandy C. John$16,902,844
Others in their field
Other Emerging Leaders on “Affinity”
- Bala Raja · Luminostics, Inc.$28,624,460
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$25,726,378
- Tharick Pascoal · University Of Pittsburgh At Pittsburgh$20,465,582
- Suzanne L Baker · University Of Pittsburgh At Pittsburgh$20,465,582
- Ashlin Bolton · Broad Institute, Inc.$19,699,069
- Timothy M Willson · University Of Cape Town$13,865,323
Research focus
AffinityAnalogAnemiaAnimal ModelBaseBiochemistryBoneBone DiseasesCareerCareer DevelopmentCell LineCell ModelCellsChronic Kidney FailureClinically RelevantClinical TrialsClustered Regularly Interspaced Short Palindromic RepeatsCollaborationsDietDisease ModelDoseEducational StatusEndocrineAdenine
Grant awards (3)
Therapeutic potential of HIF-PHDi in the control of bioactive FGF23 in CKD.$25,085
F31 · FY2021 · DK · contact PI
Therapeutic potential of HIF-PHDi in the control of bioactive FGF23 in CKD.$32,618
F31 · FY2020 · DK · contact PI
Therapeutic potential of HIF-PHDi in the control of bioactive FGF23 in CKD.$32,024
F31 · FY2019 · DK · contact PI